Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
6.59
+0.10 (1.54%)
Mar 19, 2026, 9:56 AM EDT - Market open

Ginkgo Bioworks Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
170.16227.04251.46477.71313.84
Revenue Growth (YoY)
-25.06%-9.71%-47.36%52.22%309.40%
Cost of Revenue
46.9744.5554.01204.22129.69
Gross Profit
123.18182.5197.45273.49184.15
Selling, General & Admin
183.29246.16385.031,430862.95
Research & Development
243.77424.06580.621,0531,150
Other Operating Expenses
11.472.0396.21--
Total Operating Expenses
438.46742.251,0622,4822,013
Operating Income
-315.28-559.76-864.41-2,209-1,828
Interest Income
22.6238.6157.2220.260.84
Interest Expense
--0.09-0.09-0.11-2.37
Other Non-Operating Income (Expense)
-20.94-26.27-85.6667.4-8.12
Total Non-Operating Income (Expense)
1.6812.25-28.5387.55-9.66
Pretax Income
-313.6-547.51-892.94-2,121-1,838
Provision for Income Taxes
-0.84-0.48-0.07-15.03-1.48
Net Income
-312.76-547.03-892.87-2,105-1,830
Minority Interest in Earnings
----1.44-6.6
Net Income to Common
-312.76-547.03-892.87-2,105-1,830
Shares Outstanding (Basic)
5552494234
Shares Outstanding (Diluted)
5552494234
Shares Change (YoY)
6.87%6.76%15.75%23.48%6.71%
EPS (Basic)
-5.64-10.54-18.37-50.00-54.00
EPS (Diluted)
-5.64-10.54-18.37-50.00-55.60
Free Cash Flow
-178.72-382.13-336.3-304.47-310.34
Free Cash Flow Per Share
-3.22-7.36-6.92-7.25-9.13
Gross Margin
72.39%80.38%78.52%57.25%58.68%
Operating Margin
-185.29%-246.54%-343.76%-462.41%-582.62%
Profit Margin
-183.81%-240.94%-355.08%-440.93%-585.22%
FCF Margin
-105.04%-168.31%-133.74%-63.74%-98.89%
EBITDA
-256.29-496.74-793.9-2,166-1,799
EBITDA Margin
-150.62%-218.79%-315.72%-453.50%-573.35%
EBIT
-315.28-559.76-864.41-2,209-1,828
EBIT Margin
-185.29%-246.54%-343.76%-462.41%-582.62%
Effective Tax Rate
0.27%0.09%0.01%0.71%0.08%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q